LENZ
NASDAQ · Pharmaceuticals
Lenz Therapeutics Inc
$8.69
-0.38 (-4.19%)
Open$8.91
Previous Close$9.07
Day High$9.18
Day Low$8.68
52W High$50.40
52W Low$11.83
Volume—
Avg Volume834.7K
Market Cap377.04M
P/E Ratio—
EPS$-2.11
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+60.9% upside
Current
$8.69
$8.69
Target
$13.98
$13.98
$9.74
$13.98 avg
$16.17
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 61.59M | 55.54M | 66.64M |
| Net Income | 19.38M | 14.59M | 22.25M |
| Profit Margin | 31.5% | 26.3% | 33.4% |
| EBITDA | 32.48M | 26.94M | 31.76M |
| Free Cash Flow | 24.80M | 19.95M | 25.11M |
| Rev Growth | +17.7% | +18.8% | -7.8% |
| Debt/Equity | 0.99 | 1.18 | 1.26 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |